Login to Your Account

Market Report Q212

Cash for Biotech Slows in First Half of 2012

By Peter Winter

Monday, July 9, 2012

After coming off a hot 2011 financing year it appears that the biotech sector must be flush with cash because the amount of capital generated by private and public biotech companies slowed considerably in the first half of 2012. According to statistics compiled by BioWorld Insight drawn from BioWorld Snapshots, in the first-half of 2012 biotech fundraising generated just $7.9 billion, down 40 percent from the same period in 2011 when biotech companies raised a total of $13.3 billion.

To continue reading subscribe now to BioWorld Insight

Learn More about BioWorld Insight

Already a subscriber? Sign In or Buy now to activate your subscription